Monitoring Disease Modifying Medications in Sheikh Shakhbout Medical City
Overview of the Division of Pediatric Rheumatology
The
Division of Pediatric Rheumatology at Sheikh Shakhbout Medical City (SSMC) specializes in the assessment, diagnosis, and treatment of various rheumatological conditions affecting children. This division is dedicated to providing comprehensive care for pediatric patients with autoimmune diseases, ensuring they receive the most effective disease-modifying medications (DMMs) tailored to their specific needs.
Importance of Monitoring Disease Modifying Medications
Disease modifying medications play a crucial role in managing chronic rheumatological conditions. These medications aim to alter the course of the disease, reduce inflammation, and prevent long-term damage to joints and tissues. Continuous monitoring is essential to assess the effectiveness of these treatments and to identify any potential side effects early on.
Protocols for Monitoring
At SSMC, a structured protocol is implemented for monitoring patients on DMMs. This includes:
- Regular Clinical Assessments: Patients undergo routine evaluations to monitor disease activity and medication efficacy.
- Laboratory Tests: Blood tests are conducted periodically to check for any adverse effects on organ function or blood parameters.
- Patient Education: Families are educated about the importance of adherence to medication regimens and recognizing signs of potential complications.
Multidisciplinary Approach
The management of pediatric patients on DMMs involves a
multidisciplinary team that includes:
- Pediatric Rheumatologists: Specialists who oversee the treatment plans and adjust medications as necessary.
- Nurses: Healthcare professionals who provide support and education to families regarding medication administration and side effects.
- Pharmacists: Experts who ensure that prescriptions are correctly filled and provide guidance on medication interactions.
Goal of Monitoring
The primary goal of monitoring disease-modifying medications at SSMC is to ensure optimal patient outcomes through:
- Personalized Treatment Plans: Tailoring therapies based on individual patient responses and disease progression.
- Minimizing Side Effects: Early detection and management of any adverse reactions to medications.
- Enhancing Quality of Life: Aiming for improved functional status and overall well-being for pediatric patients.
The Division of Pediatric Rheumatology at Sheikh Shakhbout Medical City is committed to providing high-quality care through diligent monitoring of disease-modifying medications. This proactive approach ensures that pediatric patients receive effective treatment while minimizing risks associated with their therapies. By fostering a collaborative environment among healthcare providers, SSMC aims to enhance the health outcomes of children with rheumatological conditions.
Why choose SSMC?
The Division of Paediatric Rheumatology includes a multidisciplinary team led by experienced consultants specialising in Paediatric Rheumatology. We adopt a multifaceted, holistic approach when assessing and treating unusual cases of autoimmune or autoinflammatory diseases. Working closely with physiotherapists, podiatrists, clinical pharmacists, nurses, and psychologists, when needed, our team fully utilises SSMC's advanced technological capabilities to deliver the finest medical care conceivable.
Special technology & unique devices
- Intra articular Triamcinolone Hexacetonide (Long acting steroid) injections for paediatric patients in our clinic and if needed, we give it under general anesthesia.
- Day Care Infusions of Intravenous steroids, biologic treatment, chemotherapy, Rituхimab, IVIG, Bisphosphonate for rheumatology patients.
- Assessment of possible recurrent fever syndrome to know its underlying causes.
